Please login to the form below
evidence
This page shows the latest evidence news and features for those working in and with pharma, biotech and healthcare.
Merck enters agreement with Hanmi for investigational NASH drug
Korea. “Data from phase 2 studies has provided compelling clinical evidence that warrants further evaluation of efinopegdutide for the treatment of NASH,” said Sam Engel, associate vice president, Merck clinical research,
Latest news
-
AbbVie, Amgen and Takeda team up for joint COVID-19 trial
coronavirus. As part of the alliance, members are sharing clinical trial data and real-world evidence, as well as crowd-sourcing early-stage candidates to identify mechanisms or treatments that could
-
Sanofi faces manslaughter allegations in France over Depakine deaths
It is not clear if Sanofi will go to trial for the charges, as France’s legal system requires prosecutors to provide specific and sufficient evidence to advance the case.
-
EMA to support real-world monitoring of COVID-19 treatments/vaccines
The project will be undertaken in collaboration with the European Health Data &Evidence Network consortium.
-
UK biotech Synairgen reveals promising early results for COVID-19 drug
Patients who received SNG001 were also more than twice as likely to recover, defined by ‘no limitation of activities’ or ‘no clinical or virological evidence of infection’, over the course of
-
NICE recommends Astellas’ Xospata for NHS use
home. It also acknowledged that the clinical evidence demonstrates that those taking Xospata live longer compared with people having salvage chemotherapy. ... Still, NICE maintained that there is ‘considerable uncertainty’ about the long-term
More from news
Approximately 13 fully matching, plus 1,661 partially matching documents found.
Latest Intelligence
-
Post-COVID-19 behaviour – the new normal or nothing new?
Once we’ve identified this, it’s about selecting the right intervention, which is derived from a set of evidence-based techniques.
-
A new era for patient services?
The future role of patient services. Pharma-sponsored patient services have a long history with a wealth of evidence that multichannel programmes using technology and personal interactions together can significantly improve
-
Why pharma must trust the science of behaviour
a growing evidence base built up over decades. Behavioural science is now widely adopted. ... Follow the evidence. Once again, such programmes rely on deep insight right from the start.
-
The search for treatments for Parkinson’s disease
to hearing the evidence.”.
-
Addressing the payer-regulator evidence gap in early-stage cancer
As more treatments are developed for earlier stages of the disease, where there is greater potential for a cure, new challenges arise in establishing evidence that satisfies both healthcare regulators and ... On the industry side, there also needs to be
More from intelligence
Approximately 9 fully matching, plus 336 partially matching documents found.
Latest appointments
-
NICE looks internally for new chief executive
During her time at NICE, she held responsibility for setting up and running the clinical guidelines programme, and for establishing the NICE implementation function and launching NHS Evidence.
-
Sciterion appoints Gabi Cutayar as new MD
I’m delighted to be part of such an energetic and passionate team who consistently bring science to life in evidence-based and creative ways,” said Cutayar.
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
Both O’Leary and Massey have experience of delivering evidence-based pricing and market access communications to help build global brands.
-
New hires at Ashfield, Hamell and Springer Healthcare
With his track record of converting complex brand propositions into multi-award-winning campaigns, Marc has what it takes to elevate the execution of Hamell’s evidence-based strategic approach to
-
New faces at 11 London, ramarketing and MSL
Experience tells me that wellbeing and digital innovation is critical to success, so you can evidence campaign impact, while engaging and involving patients.
More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest from PMHub
-
Can involving patients in design transform the clinical trial experience?
Evidence that co-design works. There’s evidence out there that people are co-designing materials with patients and incorporating their insights and preferences. ... And the result was a workbook that combined patient-driven features,
-
Combating Coronavirus Through Reversing Diabetes
The Diabetes Reversal Company has developed a pioneering programme based on sustainable weight loss, evidence-based lifestyle change and one-to-one clinical support to reduce and reverse the effects of ... We want to move away from traditional reliance
-
July 2020: diversity and inclusion in clinical trials round-up
The COVID-19 pandemic has exposed even more evidence for health disparities among different ethnic groups. ... The evidence shows that diversity in clinical trials, and a full understanding of the effects of treatments in all ethnicities really does
-
INFOSHEET 02: Improving diversity in your patient recruitment strategy
But with regulatory bodies around the world increasingly asking for evidence of drug safety and effectiveness in diverse populations, it’s vital to address these barriers in your clinical study design.
-
If our patients are diverse, why are clinical trials so white?
According to the largest study (to date) in different racial and ethnic populations across the US, there was no evidence to support the association of UV exposure and melanoma incidence in ... Meanwhile, evidence has come to light that suggests doctors
More from PMHub
Approximately 10 fully matching, plus 254 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- New study identifies drugs that are safe to use in COVID-19 treatment
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Novartis builds its case for novel MS treatment ofatumumab
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- OPEN Health at the World Orphan Drug Conference USA
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Quick links
Infographics
